TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 78 filers reported holding TANGO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,057,663 | +233.1% | 3,557,519 | -1.8% | 0.00% | – |
| Q2 2023 | $12,026,619 | -14.0% | 3,622,476 | +2.4% | 0.00% | – |
| Q1 2023 | $13,978,703 | -45.7% | 3,538,912 | -0.3% | 0.00% | -100.0% |
| Q4 2022 | $25,745,992 | +143.6% | 3,551,171 | +21.6% | 0.00% | – |
| Q3 2022 | $10,571,000 | -26.2% | 2,920,410 | -7.6% | 0.00% | – |
| Q2 2022 | $14,316,000 | +26.5% | 3,160,387 | +111.7% | 0.00% | – |
| Q1 2022 | $11,319,000 | -10.2% | 1,493,186 | +29.6% | 0.00% | – |
| Q4 2021 | $12,607,000 | -30.0% | 1,152,440 | -17.3% | 0.00% | -100.0% |
| Q3 2021 | $18,014,000 | – | 1,393,168 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $87,719,000 | 57.68% |
| TCG Crossover Management, LLC | 1,172,250 | $5,310,000 | 2.26% |
| Boxer Capital, LLC | 6,871,642 | $31,129,000 | 1.97% |
| Cormorant Asset Management, LP | 4,507,843 | $20,421,000 | 1.54% |
| Casdin Capital, LLC | 3,500,000 | $15,855,000 | 1.34% |
| Bain Capital Life Sciences Investors, LLC | 1,921,790 | $8,706,000 | 1.02% |
| Samsara BioCapital, LLC | 630,000 | $2,854,000 | 0.76% |
| Southpoint Capital Advisors LP | 4,500,000 | $20,385,000 | 0.58% |
| HARVARD MANAGEMENT CO INC | 708,385 | $3,209,000 | 0.37% |
| EcoR1 Capital, LLC | 2,302,065 | $10,428,000 | 0.36% |